132 related articles for article (PubMed ID: 29140429)
1. Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae.
Cheng MP; Bogoch II; Green K; Plevneshi A; Rudnick W; Shigayeva A; McGeer A; Lee TC;
Clin Infect Dis; 2018 Apr; 66(8):1282-1285. PubMed ID: 29140429
[TBL] [Abstract][Full Text] [Related]
2. Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia.
Cremers AJ; Sprong T; Schouten JA; Walraven G; Hermans PW; Meis JF; Ferwerda G
J Antimicrob Chemother; 2014 Aug; 69(8):2258-64. PubMed ID: 24729585
[TBL] [Abstract][Full Text] [Related]
3. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
Yu VL; Chiou CC; Feldman C; Ortqvist A; Rello J; Morris AJ; Baddour LM; Luna CM; Snydman DR; Ip M; Ko WC; Chedid MB; Andremont A; Klugman KP;
Clin Infect Dis; 2003 Jul; 37(2):230-7. PubMed ID: 12856216
[TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
Fernández Guerrero ML; Ramos JM; Marrero J; Cuenca M; Fernández Roblas R; de Górgolas M
Int J Infect Dis; 2003 Mar; 7(1):46-52. PubMed ID: 12718810
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China.
Chen R; Chen Y; Black S; Hao CL; Ding YF; Zhang T; Zhao GM
J Trop Pediatr; 2010 Jun; 56(3):204-5. PubMed ID: 19748932
[No Abstract] [Full Text] [Related]
8. A case of bacteremia due to resistant Streptococcus pneumoniae.
Rahman S; Smith MA; Alperstein P; France K
Clin Infect Dis; 1992 May; 14(5):1140-1. PubMed ID: 1600017
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae: bacteremia in an era of penicillin resistance.
Castillo EM; Rickman LS; Brodine SK; Ledbetter EK; Kelly C
Am J Infect Control; 2000 Jun; 28(3):239-43. PubMed ID: 10840344
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
Garau J
Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
[TBL] [Abstract][Full Text] [Related]
11. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
12. Resisting the urge to prescribe.
Edwards KM
J Pediatr; 1996 Jun; 128(6):729-30. PubMed ID: 8648528
[No Abstract] [Full Text] [Related]
13. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms].
Sidorenko SV
Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194
[No Abstract] [Full Text] [Related]
14. Antimicrobial selection for penicillin-resistant pneumococcal bacteremia.
Hill AR
Clin Infect Dis; 2004 Mar; 38(5):763; author reply 765-6. PubMed ID: 14986266
[No Abstract] [Full Text] [Related]
15. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
16. [The microbiologist's point of view].
Gutmann L
Presse Med; 2002 Nov; 31(37 Pt 2):S4-5. PubMed ID: 12489324
[No Abstract] [Full Text] [Related]
17. Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients.
Fontana NS; Ibrahim KY; Bonazzi PR; Rossi F; Almeida SCG; Tengan FM; Brandileone MCC; Abdala E
Sci Rep; 2021 Feb; 11(1):3699. PubMed ID: 33580101
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
Kelley MA; Weber DJ; Gilligan P; Cohen MS
Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia.
Kim BN; Bae LG; Kim MN; Park SJ; Woo JH; Ryu J; Kim YS
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):35-42. PubMed ID: 11913499
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae respiratory tract infections.
Klugman KP; Feldman C
Curr Opin Infect Dis; 2001 Apr; 14(2):173-9. PubMed ID: 11979129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
